/Investor DB

Novalis LifeSciences — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Bluewhalebluewhale.bioinOct 2025

BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.

BiotechDeep TechMedical DevicesPhiladelphia, US

Peter Keller(Executive Officer, Director)in

BoardElaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)

Board seatPaul Meister· per SEC Form D

Co-investorsAscendo VenturesBaselayer CapitalCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more

Flywheelflywheel.ioin𝕏Dec 2025 · $25M

Flywheel provides a platform for organizing, managing, and sharing medical imaging data.

AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US

Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in

Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D

Co-investors8VCAlumni VenturesBeringeaGreat North VenturesIntuitive VenturesiSelect Fund+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.